DOTLogo2017 Small Molecule Ubiquitin Protease (USP7) Inhibitors with Immune Cell Based Anti-Tumor Activity Superior to that of Biologicals
with Tauseef R. Butt, Ph.D., President and CEO, Progenra, Inc.

DOTLogo2017 Targeted Platform for RNA Therapeutics
with Dan Peer, Ph.D., Director, Laboratory of Precision NanoMedicine, Tel Aviv University

DOTLogo2017 PROTACs: The Chemical Equivalent of CRISPR
with Craig M. Crews, Ph.D., Lewis B. Cullman Professor of Molecular, Cellular, and Developmental Biology; Professor, Chemistry & Pharmacology, Yale University


DOT_Logo_2016 Advances and Challenges in the Discovery and Development of Histone Demethylase Inhibitors
with Dr. Christopher Schofield, Head of Organic Chemistry in the Chemistry Research Laboratory at the University of Oxford

2015 Podcasts

DOTLogo2016 Targeting The Unfolded Protein Response - A New Avenue for Drug Discovery
with Claudio Hetz, Ph.D., Professor, Institute of Biomedical Sciences, University of Chile; Principal Investigator, Laboratory of Cellular Stress and Biomedicine, Adjunct Professor, School of Public Health, Harvard University

DOTLogo2016 Histone Methyltransferase and Demethylase Inhibitor Discovery: Current Challenges, Novel Tools and Emerging Targets
with Trevor Perrior, Ph.D., Director, Research, Domainex Limited and Gregg Siegal, Ph.D., CEO, ZoBio

DOTLogo2016 Targeting DUBs: Drug Discovery Challenges, Enabling Technologies and Translating into the Clinic
with Xavier Jacq, Ph.D., Head of Biology, MISSION Therapeutics

2014 Podcasts

DOTLogo Development of Histone Demethylase Inhibitors for Oncological and Neurodegenerative Disease
with Tamara Maes, Ph.D., Co-Founder, Vice President & CSO, Oryzon Genomics

DOTLogo Opportunities and Challenges with Developing Small Molecule Inhibtors Targeting the Ubiquitin Proteasome System (UPS)
with Benedikt Kessler, Ph.D., University Research Lecturer, Ubiquitin Proteolysis Group, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford

DOTLogo Targeting BET Bromodomains in Cancer: In Vivo Efficacy & Toxicity, Challenges and Outlook
with Jialiang Wang, Ph.D., Assistant Professor, Neurological Surgery, Vanderbilt University